Most Read Articles
Popular Stories
RADAR on Medicare Advantage
-
Medicare Advantage Insurers Step Up SNP Offerings for 2022, Particularly for Duals
As Medicare Advantage enrollment soars and the number of individual MA plans available across the U.S. reaches a new high for 2022, the MA Special Needs Plan market is also seeing continued growth...Read More -
Clover Health Struggles to Contain Medical Costs for MA Members
Of the newly public startup insurers that reported third-quarter 2021 earnings, all four posted higher (worse) medical loss ratios (MLRs) compared with the prior-year quarter — a direct result of higher COVID-related costs...Read More
HEALTH PLAN WEEKLY
-
Insurers Applaud New CMMI Push for Risk-Based Contracting
The Biden administration has revamped the strategy of the Center for Medicare and Medicaid Innovation: In the coming years, CMMI will focus on consolidating models, increasing insurer and provider participation in models...Read More -
Executive Compensation Data for Blue Cross and Blue Shield Affiliates, 2020
See a full list of director compensation for Presidents and/or CEOs of Blue Cross and Blue Shield Affiliates, compiled by AIS Health.Read More
Radar On Speciality Pharmacy
-
Prime Therapeutics Launches IntegratedRx - Oncology, Partners on MIP Accreditation
Many people fighting cancer must get their oral oncolytics from a central fill specialty pharmacy, which can add to the time it takes for a prescription to be filled, as well as potential waste...Read More -
New Tecartus FDA Approval for Adults With ALL Offers Welcome Therapeutic Option
On Oct. 1, the FDA gave another indication to Gilead Sciences, Inc. division Kite Pharma, Inc.’s Tecartus (brexucabtagene autoleucel) for the treatment of people 18 years and older with relapsed or refractory B-cell precursor acute lymphoblastic leukemia...Read More
RADAR ON DRUG BENEFITS
-
New FDA Appointee Is Likely to Emphasize Real-World Data
President Joe Biden recently nominated former FDA Commissioner Robert Califf, M.D., to run the agency once more, ending nearly a year of temporary leadership under...Read More -
Smaller PBMs Beat Big Firms in Customer Satisfaction
Plan sponsors’ overall satisfaction with their PBMs increased from 8.0 on a 1-10 scale in 2020 to 8.2 in 2021, according to Pharmaceutical Strategies Group’s 2021 Pharmacy Benefit Manager Customer Satisfaction Report...Read More
About AIS Health
AIS Health is a publishing and information company that has served the health care industry for more than 30 years. Our mission is to provide our readers with an actionable understanding of the business of health care and pharmaceuticals. Our in-depth writing covers the companies, people, catalysts and trends that create the richly textured contours of the health care and drug industry. AIS Health maintains journalistic independence from our parent company, MMIT. We are committed to integrity in reporting and bringing transparency to health industry data.
The Latest
Premium Categories
Premium Categories
Meet Our Reporters
Meet Our Reporters
Get an actionable understanding of the business of health care and pharmaceuticals
Sign up for publications to get unmatched business intelligence delivered to your inbox.